x

Posted 26 January, 2024

Assertio Holdings, Inc. appointed new CEO

CEO Change detected for ticker Nasdaq:ASRT in a 8-K filed on 26 January, 2024.


  On January 24, 2024, Daniel A. Peisert, former President and Chief Executive Officer of Assertio Holdings, Inc. (the "Company"), executed a waiver and release agreement (the "Waiver and Release Agreement") substantially in the form included with the Management Continuity Agreement between Mr. Peisert and the Company, a form of which was filed as Exhibit 10.2 to the Company's Annual Report on Form 10-K filed on March 10, 2022. Pursuant to and in connection with his execution of the Waiver and Release Agreement, Mr. Peisert resigned as a member of the Board of Directors of the Company, effective immediately.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of Assertio Holdings, Inc.
Health Care/Life Sciences • Pharmaceuticals
Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.
Market Cap
$166M
View Company Details
Assertio Holdings, Inc. by TradingView
Relevant filing section
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. 


On January 24, 2024, Daniel A. Peisert, former President and Chief Executive Officer of Assertio Holdings, Inc. (the "Company"), executed a waiver and release agreement (the "Waiver and Release Agreement") substantially in the form included with the Management Continuity Agreement between Mr. Peisert and the Company, a form of which was filed as Exhibit 10.2 to the Company's Annual Report on Form 10-K filed on March 10, 2022. Pursuant to and in connection with his execution of the Waiver and Release Agreement, Mr. Peisert resigned as a member of the Board of Directors of the Company, effective immediately.